Evidence map›Paper›PMID 41180679›Full record

ArticleAnnals of medicine and surgery (2012)2025

Severe non-cardiogenic pulmonary edema following low-dose amlodipine ingestion: a case report.

Fares Abboud, Mustafa Zain, Ahmad Alsaadi, Ghassan Bayat, Muhanad Maaita

Abstract readCase Reports
In one paragraph

Article in Annals of medicine and surgery (2012), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Fares AbboudFaculty of Medicine, Damascus University, Damascus, Syria.ORCID https://orcid.org/0009-0003-9647-9588
Mustafa ZainDepartment of Cardiology, Al Mouwasat University Hospitals, Damascus University, Damascus, Syria.
Ahmad AlsaadiDepartment of Cardiology, Al Mouwasat University Hospitals, Damascus University, Damascus, Syria.
Ghassan BayatDepartment of Internal Medicine, Plymouth University Hospitals NHS Trust, Plymouth, UK.
Muhanad MaaitaFaculty of Medicine, Mu'tah University, Mu'tah, Jordan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction and Importance: Amlodipine, a dihydropyridine calcium channel blocker, is widely used for hypertension. While peripheral edema is common, non-cardiogenic pulmonary edema (NCPE) is rare and typically linked to overdose. This case reports severe NCPE at a low therapeutic dose. Case Presentation: A 40-year-old male with newly diagnosed hypertension, treated with amlodipine 5 mg and valsartan 160 mg daily for 4 days, was presented with severe sudden dyspnea, palpitations, and restlessness. Examination revealed bilateral lung crackles, oxygen saturation of 68%, and a respiratory rate of 38 breaths/min. Imaging and a pulmonary capillary wedge pressure of 8 mmHg confirmed NCPE. Amlodipine was discontinued, and hydrochlorothiazide 12.5 mg daily was initiated, leading to rapid improvement. Three months later, symptoms recurred 7 hours after accidental ingestion of two 5 mg amlodipine tablets, resolving upon cessation. Clinical Discussion: This is the first reported case of severe NCPE associated with low-dose amlodipine, confirmed by low wedge pressure and normal echocardiography. Recurrence after re-exposure suggests a possible association, though causality remains unconfirmed. Conclusion: This case highlights a potential rare association between low-dose amlodipine and severe NCPE, warranting further investigation. Clinicians should consider amlodipine in unexplained NCPE cases, with early discontinuation to improve outcomes.

Indexed as

amlodipinecalcium channel blockershypertensionnon-cardiogenic pulmonary edema

Identifiers

PMID41180679
PMCPMC12577906

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.